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Abstract
Background: Neonatal mortality remains high in rural Nepal. Previous work suggests that local women’s groups
can effect significant improvement through community mobilisation. The possibility of identification and
management of newborn infections by community-based workers has also arisen.
Methods/Design: The objective of this trial is to evaluate the effects on newborn health of two community-based
interventions involving Female Community Health Volunteers.
MIRA Dhanusha community groups: a participatory intervention with women’s groups. MIRA Dhanusha sepsis
management: training of community volunteers in the recognition and management of neonatal sepsis.
The study design is a cluster randomized controlled trial involving 60 village development committee clusters
allocated 1:1 to two interventions in a factorial design.
MIRA Dhanusha community groups: Female Community Health Volunteers (FCHVs) are supported in convening
monthly women’s groups. Nine groups per cluster (270 in total) work through two action research cycles in which
they (i) identify local issues around maternity, newborn health and nutrition, (ii) prioritise key problems, (iii) develop
strategies to address them, (iv) implement the strategies, and (v) evaluate their success. Cycle 1 focuses on maternal
and newborn health and cycle 2 on nutrition in pregnancy and infancy and associated postpartum care practices.
MIRA Dhanusha sepsis management: FCHVs are trained to care for vulnerable newborn infants. They (i) identify local
births, (ii) identify low birth weight infants, (iii) identify possible newborn infection, (iv) manage the process of
treatment with oral antibiotics and referral to a health facility to receive parenteral gentamicin, and (v) follow up
infants and support families.
Primary outcome: neonatal mortality rates. Secondary outcomes: MIRA Dhanusha community group: stillbirth, infant and
under-two mortality rates, care practices and health care seeking behaviour, maternal diet, breastfeeding and
complementary feeding practices, maternal and under-2 anthropometric status. MIRA Dhanusha sepsis management:
identification and treatment of neonatal sepsis by community health volunteers, infection-specific neonatal mortality.
Trial Registration no: ISRCTN: ISRCTN87820538
Background
The importance of newborn survival
The fourth and fifth United Nations Millennium Devel-
opment Goals are linked explicitly with maternal and
child survival[1]. 11 million children under five die each
year, 4 million of them in the neonatal period and 98%
in developing countries [2,3]. The decline in post-
neonatal mortality through immunisation, control of
diarrhoeal disease and treatment of acute respiratory
infection has increased the relative importance of the
newborn period [3,4].
Nepal has an infant mortality rate of 51 per 1000 live
births and a neonatal mortality rate of 34: [5] newborn
deaths comprise 66% of child deaths. Primary and sec-
ondary care is deficient, most women have no antenatal
care and most deliveries occur at home. The 2006
Nepal Demographic and Health Survey showed that
13.5% of rural women and 4.3% of the poorest wealth
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quintile had given birth in a health facility and that
skilled attendance at delivery only reached 14.3% of
rural women[5]. Most stillbirths and neonatal deaths
also occur at home, and many might be avoided with
changes in antenatal and newborn care practices. Efforts
to improve access to care have to deal with difficult ter-
rain and lack of infrastructure, limited expenditure on
public health, suboptimal quality of care, a high turn-
over of service providers, a lack of drugs and supplies,
and a lack of ownership of health programmes by
communities.
Community intervention to improve newborn survival
In India, the SEARCH group reported a controlled study
from a rural population of about 80,000 in Gadchiroli,
Maharashtra[6]. At baseline, almost half of newborn
infants encountered high-risk morbidity, commonly due
to sepsis. In intervention villages, SEARCH trained tra-
ditional birth attendants, introduced health education,
and developed a new cadre of supervised village health
workers to visit newborn infants at home, identify warn-
ing signs and manage sepsis with a combination of
injectable and oral antibiotics. By the third year of the
intervention, the neonatal mortality rate was 26 per
thousand live births in intervention and 60 per thousand
in control villages. So far, the employment and manage-
ment of health workers outside the government system,
and the reluctance of government and professional
bodies elsewhere to sanction delivery of injectable anti-
biotics by community health workers, have limited the
model’s scalability. However, adaptations of the model
have been evaluated in Bangladesh,[7] India,[8] and
Pakistan, [9] using home visits by community health
workers for rapid referral but without using injectable
or oral antibiotics in the home, and with varying degrees
of success.
Community intervention to treat childhood infections
It has become clear that the management of childhood
infections - particularly acute respiratory infections - by
community health volunteers is feasible and effective.
The WHO recommends a combination of three strate-
gies: improving quality of care and accessibility at first-
level public health facilities, improving quality of care in
the private sector, and increasing access to care through
the work of community health workers. These latter can
be trained to assess, counsel, treat, refer and follow up
children with pneumonia in the community[10]. Meta-
analysis suggests that such approaches can lead to a
reduction of 24% in total mortality and 36% in pneumo-
nia mortality in children under five years old[11].
Much of the work on community management of
pneumonia was done in Nepal. The model has been
taken to scale through 54 000 female community health
volunteers. At present, the programme covers infants
and children over the age of two months, but there is
concern that it should be expanded to cover younger
infants. The Morang Innovative Neonatal Intervention
(MINI), implemented by the Ministry of Health and
Population, with technical support from John Snow
International and funding from The Bill and Melinda
Gates Foundation through Saving Newborn Lives and
Save the Children USA, trains existing Female Commu-
nity Health Volunteers and peripheral government
health workers to identify and manage neonatal infec-
tions [12-14] using oral antibiotics in the home (cotri-
moxazole) and to refer rapidly to the nearest health
facility for treatment of sepsis cases with injectable gen-
tamicin. This pilot study has shown good referral rates
and reduction in case fatality rates, but there is no con-
trol group comparison, and it is uncertain whether these
results could be reproduced at scale in the government
system.
Working with women’s groups
The Warmi project, implemented in Bolivia in a poor,
rural population of 15,000 with little health system
infrastructure, worked with women’s groups to encou-
rage participatory planning for mother and infant care,
[15] and documented a fall in perinatal mortality from
117 to 44 per thousand births over three years. Building
on this example, we conducted the MIRA Makwanpur
trial in a population of 170,000 in a middle hills rural
district of Nepal. One woman facilitator per population
cluster of 7000 facilitated monthly meetings with
women’s groups to address the issues of pregnancy,
childbirth and newborn health. Each group moved
through a participatory planning cycle to explore perina-
tal care strategies and solutions[16]. The large cluster
randomised controlled trial suggested that participatory
work with women’s groups could reduce neonatal mor-
tality by 30%[17]. From a conservative viewpoint, the
study at least demands replication and assessment of
modifications that would make it scalable and institu-
tionally sustainable within a national public health fra-
mework. A recent replication trial conducted in India’s
Jharkhand and Orissa states achieved a 45% reduction in
neonatal mortality in a population with very high base-
line mortality rates [18].
There is no doubt that improvements to women’s
diets are needed, particularly from a life-cycle perspec-
tive, and little doubt that behaviour change could
improve the health of both women and their infants.
However, programmatic effectiveness to achieve beha-
viour change remains unclear[19,20]. Nutrition is inti-
mately linked with social development, and we propose
that a community mobilisation intervention that has led
to improvements in maternal and neonatal survival
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could also be a route into dietary behaviour change. The
demand-side approach is a model that may sustain a
range of issues. The MIRA Makwanpur study addressed
the issues of pregnancy, delivery and newborn care. It
did not, however, include any discussions about diet and
nutrition. There is ample scope for such discussions to
be included in one or more action research cycles, and
for local strategies to improve the nutritional status of
women to be formulated. We should like to examine
the potential for including nutritional issues in the com-
munity group work.
Nepal’s Female Community Health Volunteers
The Female Community Health Volunteer (FCHV) role
is a grassroots worker. She is nominated by a mother’s
group, becomes its member secretary and is responsible
for facilitating the group itself and for building linkages
with the health system at village level. In general, one
FCHV is allocated per ward, of which there are 9 in
each Village Development Committee. There are up to
54 000 FCHVs in Nepal: 48 550 in rural village develop-
ment committees and 5450 in municipalities.
Initial training on primary health care lasts 18 days.
Mother and child health and family planning are a parti-
cular focus. FCHVs receive five days of refresher train-
ing per year, usually on issues such as HIV/AIDS,
sexually transmitted infections, nutrition and the Inte-
grated Management of Childhood Illness. Supervisory
responsibility rests with the District Public Health
Office, and FCHVs meet with their local health facility
supervisors once per month and the District Public
Health Officer every six months.
The FCHV has a number of specific responsibilities:
facilitation of the mother’s group, counselling on family
planning and distribution of contraceptives, contribution
to the community component of the integrated manage-
ment of childhood illness, health education, safer
motherhood referral services, immunization with an
emphasis on oral polio vaccine and tetanus toxoid, dis-
tribution of vitamin A, anthelminthics and iron supple-
ments, management of minor illnesses and injuries, and
nutrition education [21]. FCHVs are not salaried, but
receive support for attending training and incentives for
particular activities.
The SEARCH findings from rural India have shown
that treatment of newborn infections in the community
using paid workers to visit homes and provide injectable
antibiotics can significantly reduce neonatal mortality
[6]. The intervention was complex and scaling up pre-
sents difficulties for policymakers. Nepal’s Acute
Respiratory Infection programme, however, has been
successful in achieving broad coverage by FCHVs to
provide oral antibiotics and referral advice for children
with signs of acute respiratory infection. At present, the
programme covers infants and children over the age of
two months. We wish, therefore, to do two things: first,
to build on and simplify the Indian model on a frame-
work that targets scalability; second, to test the effective-
ness of expanding the programme activities to cover the
newborn period, a move supported by the Nepal Family
Health Programme and others. We have collaborated
with and learnt from the MINI project, which has devel-
oped extensive training and monitoring packages for
community-based management of newborn infections.
Methods/Design
Trial objective
We are carrying out a trial of two models of interven-
tion to improve child survival.
MIRA Dhanusha community groups: a participatory
intervention with women’s groups
FCHVs are supported in convening monthly women’s
groups. Nine groups per cluster (270 in total) work
through an action research cycle in which they (i) iden-
tify local issues around maternity, newborn health and
nutrition, (ii) prioritise key problems, (iii) develop strate-
gies to address them, (iv) implement the strategies, and
(v) evaluate their success. They then move on to a sec-
ond action cycle focused on nutrition, in which they fol-
low the same steps (i to v), but concentrate on maternal
and infant nutrition and associated aspects of postpar-
tum care. Our main objective is to test the replicability
and scalability of the women’s group interventions
focused on maternal and newborn health described
above (from Makwanpur, Nepal and Jharkhand and
Orissa, India) in reducing neonatal mortality and, in the
second action cycle, to explore the potential for this
approach to improve maternal and infant nutrition.
MIRA Dhanusha sepsis management
FCHVs are trained to care for vulnerable newborn
infants. They (i) identify local births, (ii) identify low
birth weight infants, (iii) identify possible newborn infec-
tion, (iv) manage the process of treatment with oral
antibiotics (Amoxicillin) and referral to a health facility
to receive parenteral gentamicin, and (v) follow up
infants and support families. We aim to build on opera-
tional research studies in Nepal that have shown that
the approach is feasible, by testing the effect on mortal-
ity at population level.
Design
The methodology is a cluster randomized controlled
trial. A cluster design has been chosen because the unit
of randomisation is the village development committee
rather than the individual mother and child. The study
has a factorial design, summarized in Figure 1. 60 village
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development committee clusters are selected randomly.
Each cluster has a population of about 8000. 30 clusters
are allocated randomly to receive the women’s group
intervention and 30 act as controls. From each of these
two arms, 15 clusters are randomly allocated to receive
the community health volunteer training intervention.
Primary Research questions
1. What is the impact of a participatory intervention
with women’s groups on neonatal mortality?
2. What is the impact on neonatal mortality of train-
ing community health volunteers on the recognition and
management of neonatal sepsis?
Secondary research questions
1. What is the impact of a participatory women’s group
intervention that focuses on nutrition and feeding prac-
tices on the nutritional status of women and their
young children?
2. What is the impact of a participatory intervention
with women’s groups on infant and under-2 mortality?
3. What is the impact on early infant mortality of
training community health volunteers on the recognition
and management of neonatal sepsis?
Hypotheses
1. A participatory intervention with women’s groups will
be associated with reductions in neonatal mortality.
2. Training of community volunteers in the recogni-
tion and management of neonatal sepsis will be asso-
ciated with increases in identification and treatment of
neonatal sepsis, and improvements in neonatal
mortality.
3. A participatory intervention in which women ’s
groups discuss diet and nutrition will be associated with
positive changes in maternal diet and infant feeding, and
in anthropometric status of women and their young
children.
Setting
The programme is implemented in Dhanusha district,
where MIRA has been working since 2001. The admin-
istrative centre in Janakpur municipality - which is
excluded from the trial - manages a local team of
researchers, health workers and field workers, as well as
maintaining excellent relations with both hospital colla-
borators and the District Public Health Office. Dha-
nusha is a terai (lowland) district of 1180 km2.
According to the 2001 census, it had a population of
670 000 (about 20 000 per doctor) and was the fifth
most populous district in Nepal. The average household
size was 5.72[22]. Dhanusha’s human development
index, a composite measure of three dimensions of
human development–a long and healthy life, access to
education and a decent standard of living [23] was 0.449
(rank 43/75), compared with the national average of
0.471, in 2004[24]. 89% of Dhanusha’s population are
rural, 42% have access to toilet facilities and 93% have
access to improved sources of drinking water[22,25].
The commonest language spoken is Maithili and the
Sepsis management intervention
Community group intervention
Sepsis management intervention
Community group intervention
15 clusters 15 clusters 15 clusters
60 clusters
30 clusters
Community group intervention
15 clusters
Stratified Randomisation 1
Randomisation 2
30 clusters
Health service strengthening
For essential newborn care
All facilities in Dhanusha 
Random selection of 
remaining clusters
Exclusion of small and conflict-
affected clusters
Figure 1 Design of the study. Essential Newborn Care training was provided throughout the district, followed by exclusion of small and
conflict-affected clusters and stratified block randomisation on the basis of cluster size to women’s groups intervention and control. A second
block randomisation allocated equal numbers of clusters to sepsis management intervention within each women’s group study arm.
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majority religion Hinduism (88.7%), followed by Islam
(8.7%).
Target group
The main beneficiaries of the study are women of repro-
ductive age (15-49 years), of whom there were 140 000,
according to Dhanusha District Public Health Office
data for 2004-5, and infants under one year of age, of
whom there were 19 000. 26 000 pregnancies were
expected annually in the district and the crude birth
rate was 29.5 per 1000 population. About 72% of
women cannot read or write[26].
Key participants are women who either join commu-
nity groups or have a pregnancy. The women’s group
intervention involves social mobilisation and group
membership and activities are not restricted to women
of reproductive age. Since the aim is to improve the
situation of pregnant women and their newborn infants,
any participant who may affect this may be involved.
Particular stakeholders may be older women, male com-
munity members, health workers and local opinion for-
mers. Experience from other sites has shown that
women form the core membership of groups and that
both women of reproductive age and older women get
involved. All women and their newborn infants are eligi-
ble to participate in the data collection exercise, for
which enrolment occurs in the postnatal period.
Intervention group activities: MIRA Dhanusha community
groups
Each FCHV is already tasked with women’s group activ-
ities under current government guidelines, although
most groups were not meeting regularly before the
study began. FCHVs are trained and supported in acting
as facilitators for women’s groups, according to guide-
lines developed by the intervention team. Groups are
strengthened where they already exist, and initiated
where they do not. In general, there is one women’s
group per ward, corresponding with nine per cluster
and 270 over the whole intervention area. FCHVs con-
vene women’s groups monthly. Because around 60% of
FCHVs in Dhanusha are illiterate, a literate co-facilita-
tor, selected by the community group, assists the FCHV
in running the group. The primary newborn and mater-
nal health cycle, following a similar agenda to that used
in the MIRA Makwanpur trial,[16] but with additional
nutritional content, comprises nine pre-implementation
meetings, a community meeting to share problems,
plans and enlist community support, an implementation
phase and an evaluation (summarized in Figure 2). The
monthly meetings proceed from discussions of illness,
mortality and poor nutrition in mothers and babies, via
discussions of common problems in the community and
the collection of local information by group members,
to prioritisation of the most important problems. Fol-
lowing this, strategies to address these problems are
formulated, shared with the wider community and
implemented. Finally, the groups themselves evaluate
the effects of the strategies and then move on to further
activities and discussions. The FCHVs assist the
women’s groups in devising local strategies to realisti-
cally tackle the issues in a resource-constrained context.
Community commitment and ownership are essential
to ensure implementation. The FCHV’s brief is to acti-
vate and strengthen women’s groups, support them in
identifying and prioritising maternal and neonatal pro-
blems, help to identify possible solutions and support
the planning, implementation and monitoring of the
solution strategies in the community.
Formative research on beliefs and practices in preg-
nancy and postpartum informed the design of a second
cycle of monthly meetings focused on nutrition. The
meetings cover socio-cultural problems or barriers asso-
ciated with the following: nutrition in pregnancy; high
prevalence of low birth weight; nutrition, hygiene and
postpartum care of the mother; early and exclusive
breastfeeding; and complementary feeding of the infant
at six months (see Figure 2 for sequence of meetings).
The pattern of the second action research cycle is the
same as cycle one: after a pre-implementation phase
covering the topics outlined, a community meeting is
held to enlist support and share ideas. Then, over sev-
eral months the groups implement strategies to address
the nutrition-related and/or maternal and child health
related problems they prioritise, and finally evaluate
these strategies. Strategies initiated during the first
action cycle may continue to be implemented by the
groups during the second cycle and also after the imple-
mentation period.
Process evaluation is used to document each group’s
progress through the monthly meeting cycles, recording
group attendance, outcomes or decisions from indivi-
dual meetings, problems prioritised, strategies imple-
mented, progress with strategies and findings from the
participatory evaluations.
Intervention group activities: MIRA Dhanusha Sepsis
management
Our focus is on training FCHVs in the recognition and
management of neonatal sepsis. MIRA has programma-
tic experience in health service strengthening at all
levels. This relates mainly to the training of cadres from
FCHVs to doctors in essential newborn care. MIRA is
the key trainer in this field in Nepal, and has produced
materials for all levels of cadre in collaboration with the
National Health Training Centre of the Department of
Health Services. We are building on this experience to
devise and implement a new training and support pro-
gramme for FCHVs. This programme focuses on the
identification and management of neonatal sepsis. Its
technical content was developed in consultation with
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national and international authorities, and is in line with
multilateral maternal and child health programming.
FCHV activities are summarized in Figure 3. Her key
role is to identify within 24 hours all babies born in her
ward working area, and provide their families with birth
record forms to facilitate registration. The FCHV routi-
nely follows-up a baby, regardless of birth weight
categorisation, at 3, 14 and 28 days. She identifies low
birth weight infants with a simple colour-coded spring
balance, and provides advice and support on their care.
Low birth weight babies are identified by a red or yellow
zone on the spring balance, and referred to a health
facility if very low birth weight (in the red zone of the
scale). She is also trained to identify local and severe
Figure 2 The sequence of women’s group activities. Meetings conducted on a monthly basis between May 2007 and April 2011 by 270
groups in 30 study clusters. Strategies initiated after meeting 10 in both cycles may be implemented continually while meetings on other topics
are ongoing and also after the end of the intervention period.
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bacterial infection in any baby by recognition of 10 dan-
ger signs, including fever > 38°C, temperature < 36°C,
lethargy, not feeding, weak or absent cry, fast breathing,
grunting, chest in-drawing, umbilical infection with red-
ness all around or pus seepage, and more than 10 small
skin pustules or one big abscess or pustule. Local infec-
tions are treated on site and followed up to make sure
that they are settling. Skin infections are treated with
gentian violet and oral amoxicillin is provided if more
than 10 skin pustules or an umbilical infection are
found. Eye infections are treated with chloramphenicol
eye ointment. Possible severe bacterial infection, as iden-
tified by the presence of one or more danger signs, trig-
gers a sequence of activities. The FCHV gives the first
Figure 3 Flowchart of community-based sepsis management of babies 0-2 months by Female Community Health Volunteers in
Dhanusha. Actions and decisions undertaken by FCHVs when checking birth weight and for signs of possible local bacterial infection or
possible severe bacterial infection in babies born in their working areas.
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dose of oral antibiotic (amoxicillin) in the home and
shows mothers and carers how to administer further
doses by suspending it in breast milk and spoon-feeding
it to the baby morning and evening for seven days. The
FCHV then calls a MIRA supervisor to check on the
baby and also arranges and checks on referral to a
health facility. The FCHV checks on the baby on the
third day after first administering amoxicillin. If the
baby has improved, she records this and again visits on
the seventh day after starting the amoxicillin. If the baby
does not improve at three days the FCHV calls the
MIRA supervisor to visit and check on the baby again.
Although checking at days three and seven after identi-
fying the infection is required, where possible the FCHV
checks daily on babies with infection as they are usually
living nearby. In the case of low and very low birth
weight or possible infection in the first week, she visits
for follow-up at 3, 7, 14 and 28 days (an extra visit at 7
days on top of the routine timetable).
The concept of home treatment is a new one. It has
arisen from two realities: (a) that community workers
are already treating infection in older infants with oral
antibiotics, and (b) that referral advice is not always
acted upon. There are strong cultural taboos against
taking newborn infants out of the home and opposition
to the concept of giving them injections. In this situa-
tion, we feel that - even though the counsel of perfec-
tion is to give the infant parenteral antibiotics - oral
antibiotics represent a first step and a realistic response
to the prevailing situation[27].
The choice of oral antibiotic is amoxicillin. This
choice was made at an expert meeting in Kathmandu in
2006, by a committee that included the Director General
and representatives of the Department of Health Ser-
vices, the president of the Nepal Paediatric Society,
senior consultants from Patan Hospital, the Maternity
Hospital, the Institute of Medicine, Kanti Children’s
Hospital, the Nepal Health Research Council and Save
the Children US. For infants of less than two months of
age with suspected serious bacterial infection, Amoxicil-
lin is given orally in a dose of 62.5 mg twice daily for
seven days. In cases where families agree to take their
infants to health facilities, referral to health workers is
followed by treatment with gentamicin at a dose of 5
mg/Kg intramuscularly, daily for seven days. The gov-
ernment health workers tasked with providing these
intramuscular injections are already practised at admin-
istering immunisations. In order to reduce risk, they
were trained specifically in gentamicin administration at
the start of the intervention.
Supervision to ensure safety and to maintain quality
The interventions were devised by a team of paediatri-
cians (DSM, AC and DO), the project manager (BS),
who is trained to Health Assistant level, and a specialist
in community mobilisation (NS). Whilst the interven-
tions are conducted by community volunteers with no
clinical training, safety of the sepsis intervention is
ensured by involving existing government health work-
ers in the supervision of the FCHVs and by making sure
that FCHVs only refer infants to approved trained gov-
ernment health providers. In addition, each baby with
suspected infection is visited by a MIRA supervisor who
is trained to the level of either Auxiliary Nurse Midwife
or Community Medical Assistant. In cases where par-
enteral antibiotics are required the supervisors encou-
rage the family to take the baby to the health facility for
intramuscular injections.
It could be argued that providing the FCHV with oral
amoxicillin might delay the provision of parenteral anti-
biotics and therefore increase risk. The reality is that
few families feel comfortable with taking newborn
infants to health facilities, and with them receiving
injections. This means that uptake of gentamicin treat-
ment is low and that our intervention is unlikely to
increase the risk over the community norm.
Regular reporting and meetings ensure that safety and
adverse effects are monitored. Whilst no adverse effects
of the women’s group intervention were expected, pre-
paration of health messages and materials (e.g. picture
cards) was closely monitored to ensure compliance with
current recommendations.
Potential for contamination
There are two main sources of contamination, the first
between interventions under test, and the second
between intervention and control clusters.
Contamination between interventions
both the women’s group intervention and the sepsis
management intervention are being implemented
through FCHVs. FCHVs who are trained to facilitate
women’s groups may develop better communication
skills and become more mobilised to conduct their sep-
sis management activities than FCHVs who do not take
part in the women’s group intervention. Similarly,
women who are involved in the groups may become
aware of the sepsis management intervention and spread
positive information in the community, which could
make families more receptive to the FCHV’s assistance
when she visits on sepsis management work. On the
other hand, the extra workload that women’s groups
impose on FCHVs could decrease the time they have to
devote to making visits to identify, treat and follow-up
sick newborns; or sepsis management activities could
decrease the time available to undertake women’s group
activities. The extent to which women’s groups enhance
or detract from the implementation and impact of the
sepsis management intervention (and vice versa) will be
addressed by comparison of descriptive statistics for
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clusters implementing both interventions with those
implementing single interventions and control clusters.
We shall compare respondents who participated in
women’s groups with those who did not, and respon-
dents who received sepsis treatment when their child
was ill with respondents whose children fell ill but did
not receive the intervention. Both process indicators
(coverage of sepsis and women’s groups) and outcomes
will be examined in a process evaluation. Focus groups
and semi-structured interviews with FCHVs, MIRA staff
and recipients of the interventions will explore percep-
tions of how the interventions supported and interacted
with one another in practice.
Contamination between intervention and control clusters
The likelihood of the sepsis management intervention
contaminating non-sepsis intervention areas is low
because each FCHV only works in her own ward. How-
ever, since the women’s group intervention is based
around a concept of messages being transferred within
communities, there is potential for women’s group mes-
sages to spread from intervention into control and non-
study areas. This is increased because some women
move between their marital and parental homes during
the childbearing period (mid-pregnancy to around two
months postpartum), which means they may move in
and out of intervention areas and also in and out of
study areas. This is something that we cannot control.
We decided it was not feasible to create buffer zones
between intervention and control areas to control con-
tamination because the plains of Nepal are densely
populated and relatively accessible, which means that
messages may move quite long distances. In addition,
after excluding small and politically disrupted clusters
there were insufficient to choose from to evenly create
buffer zones around intervention clusters. Selection of
individual communities within VDC clusters would have
decreased sample size and might have caused conflict in
an already conflict-affected area.
As an alternative to creating buffer zones, the surveil-
lance questionnaire was designed to detect contamina-
tion between interventions by asking respondents
whether they had heard of or attended the women’s
groups and whether they had received sepsis manage-
ment visits from FCHVs. The locations and amount of
time spent in marital and parental homes during preg-
nancy and postpartum, and the location of the birth,
were recorded so that we could estimate the exposure of
each mother-baby pair to the interventions under test.
Study duration
Trial activities cover a span of six years. Two years to
mid-April 2007 were occupied with staff recruitment,
planning, community entry and collection of baseline
data. Baseline surveillance of vital events, births and
deaths, using the same tools as those used during the
trial, ran from 1 September 2006 to 13 April 2007 (the
end of the Nepalese calendar year). Due to unexpected
insurgency during 2007-8, interventions were allowed a
run-in period of one year from 14 April 2007 to 12
April 2008 as they became established in the midst of
considerable disruption. The full-scale intervention is
running 13 April 2008 to 13 April 2011 (coinciding with
Nepali calendar years 2064-2067). May - December
2011 will be taken up with an endpoint nutritional
anthropometric study (not included in this protocol),
sustainability activities, data cleaning, analysis and pre-
paration for dissemination and publication.
Randomisation and allocation
Originally, a sample size calculation was undertaken
which indicated that 48 clusters should be sufficient for
analysis of the primary neonatal mortality outcome.
However, since the Maoist insurgency in Nepal was still
very disruptive to field activities at the time of setting
up the trial, we decided to randomise 60 clusters instead
of 48 in case of loss to follow-up due to insurgency.
This amounted to an extra 3 clusters in each of the allo-
cation groups of women’s group only, sepsis only,
women’s group and sepsis, and no intervention. 60 rural
clusters were selected randomly from the 101 in the dis-
trict (Janakpur municipality has been excluded from the
study). Because of the ongoing conflict, eight village
development committee areas were excluded from sam-
pling on the basis of serious working difficulties. A
further 14 were excluded because their populations were
less than 4000. 60 clusters were then selected for the
study - from a potential list of 79 - using a random
number sequence generated in Microsoft Excel.
The first allocation (to the women’s group interven-
tion) was done in two strata. A stratum of eight very
large village development committees was block rando-
mized to either intervention or control, and the remain-
ing stratum of 52 was treated similarly. In the second
allocation, the two groups of 30 were block randomized
to either sepsis management intervention or control.
Measures
Primary outcome
neonatal mortality rates.
Secondary outcomes
MIRA Dhanusha community groups stillbirth, infant
and under-two mortality rates; care practices and health
care seeking behaviour; maternal eating behaviour in
pregnancy and postpartum; exclusive breastfeeding and
complementary feeding; maternal and young child
(under-2) anthropometric status (body mass index, Z
scores for height-for-age, weight-for-age and weight-for-
height).
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MIRA Dhanusha sepsis management identification and
treatment of neonatal sepsis by community health
volunteers, infection-specific neonatal mortality assessed
by community verbal autopsy.
Sample size
Sample size is based on the primary outcome of neona-
tal mortality rate. Calculations are based on the equa-
tions of Hayes and Bennett,[28] assuming two treatment
groups, unmatched clusters of approximately equal size,
a value of k - the between-cluster coefficient of variation
- equal in intervention and control groups, and the addi-
tion of 2 to the estimated cluster number to account for
loss of degrees of freedom consequent on stratification.
The value of k was set at 0.3 on the basis of estimates
from the MIRA Makwanpur study. A sample size of 48
clusters (24 intervention, 24 control), with an average
190 annual births documented over 2 years (i.e. 380 per
cluster), would have 80% power to detect a 30% fall in
neonatal mortality rate from 36.0 to 25.2 per 1000 at
95% significance level.
Data collection
Data is collected from five sources, using pretested for-
mats, modifications of which were adapted on the basis
of field experience during the baseline data collection
period of Sept 2006 - April 2007.
Source 1
District Development Committee and District Public
Health Office records. These sources provided baseline
data mainly based on projections from the 2001 Nepal
census at the cluster level on demographics, socioeco-
nomic status, livelihoods and health activities.
Source 2
MIRA Dhanusha vital registration system. We set up a
surveillance system for all births and newborn, infant,
child and female deaths in the 60 village development
committee clusters covered by the study. The design
and implementation of the surveillance system used in
the MIRA Makwanpur study have been described and
are available in programme publications [29]. We have
implemented similar systems in rural Bangladesh[30],
rural and urban India[18,31], and rural Malawi [32].
Field-based enumerators, recruited locally in cluster
sub-areas, identify births and deaths, and interviewers
who visit the household verify these vital events.
Individual interviews were collected for all 6292 births
in the baseline period. Subsequently, 10 births identified
in each month are selected randomly for interview.
Interviewers usually visit at about four to six weeks after
birth to administer the surveillance questionnaire and
(except for periods where insurgency disrupts activities
severely) questionnaires are usually taken before 3
months from the birth. The questionnaire collects
information on socioeconomic factors including food
security, demography, maternity history, antenatal, deliv-
ery and postnatal care, newborn care and health care
seeking, maternal eating practices during pregnancy and
postpartum, infant feeding practices and awareness of
and exposure to the interventions under test.
For all maternal or under-5 child deaths, interviewers
administer a verbal autopsy questionnaire together with
selected sections of the birth surveillance questionnaire
that do not overlap with information in the verbal
autopsy. By the end of the trial we will have more than
2500 perinatal verbal autopsies, around 600 under-5 ver-
bal autopsies, more than 100 maternal verbal autopsies
and basic information on more than 400 non-maternal
deaths of reproductive age women. In general a longer
gap is allowed after deaths before verbal autopsy inter-
views are taken to allow the bereaved family time to
mourn. Unless insecurity disrupts activities or the
bereaved family refuses to discuss the death, verbal
autopsies are usually completed within 3 months of the
event. However in a small proportion of cases interviews
may be taken as long as a year after the event once the
family feels able to talk about it.
Analyses may account for sampling bias introduced by
sampling all deaths and only a sample of births, by
using weights based on the total numbers of births and
deaths each month in each cluster, available from the
vital surveillance dataset. If needed we may also control
for recall bias by including a term for time after the
event that questionnaires were taken.
The surveillance system was run for six months before
the start of the interventions in order to develop a base-
line picture (for infants born between 1 Sep 2006 and
14 April 2007) generating a total of c.6200 surveillance
questionnaires. Around 6200 births or neonatal deaths
are surveyed annually for each year of the trial making
c.25 000 between the trial run-in year and the end of
year 3 of the trial (i.e. between baby dates of birth or
death 13 April 2007 and 13 April 2011).
The vital events database, which contains all vital
events, will have c.6200 live and still births during the
baseline period and c.11500 births per year during each
year of the trial, making a total of c.46 000 live and still
births to include in cluster level analyses over the 4 trial
years (i.e. run-in year plus years 1 to 3).
Source 3
FCHV reporting system. Based on the experience of the
MINI project, we strengthen and adapt the reporting
system for FCHVs and health workers in the clusters in
which the sepsis management intervention is intro-
duced. The data include numbers of live births, still-
births and deaths within two months that the FCHVs
detect, and the proportion of infants who get the mini-
mum requirement of 4 follow-up visits and birth weight
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measurement within 24 hours of delivery. In addition,
numbers of low birth weight infants, details of danger
signs identified, numbers of infants diagnosed with pos-
sible serious and possible local bacterial infections, num-
bers complying with amoxicillin treatment, number
referred for gentamicin injection and numbers who
received injections are recorded by MIRA health super-
visors by scrutinising FCHVs’ pictorial recording sheets.
These data can then be compared with (i) vital surveil-
lance data to estimate proportions of births and deaths
identified in each FCHV’s working area, and (ii) with
caregiver’s recall of FCHV activities in the sepsis man-
agement intervention areas.
Source 4
Ancillary studies and data collection. We collect infor-
mation on household economy and dietary practices
with targeted studies. Both quantitative and qualitative
methods are used, depending on particular questions.
Source 5
Process evaluation data collection. We collect informa-
tion on the context of the interventions, how they were
implemented in theory and practice, the impact on
group members, non-group members and communities.
Detailed data on monthly group attendance, meeting
summaries, problems prioritised, strategies being imple-
mented and progress with strategy implementation are
collected. Both quantitative and qualitative methods are
used.
Quality control
Vital events identified by enumerators are confirmed by
interviewer visits to the household, first to verify the
event and later to fill in a questionnaire. Field supervi-
sors observe 10% of contacts. A data auditor checks
forms for completeness and quality. Data are entered
into an electronic relational database management sys-
tem in Microsoft Access, and backed-up regularly on a
server partition and on compact discs.
Interim analyses
A Data Monitoring Committee (DMC) will meet in
early 2011, according to DAMOCLES guidelines [33].
Unfortunately, restrictions of movement due to security
issues during the 2007-2009 insurgency resulted in pro-
blems with database systems that could not be resolved
early enough to hold a DMC at the preferred trial mid-
point (early 2009).
Safety issues
We do not expect any negative effects of the women’s
group intervention. Harmful effects of the sepsis inter-
vention have been minimised by (i) limiting the work of
the FCHV to basic weight categorisation and diagnosis,
(ii) FCHVs administering well-tested drugs in small
doses, and (iii) by involvement of clinicians in
supervising the intervention. Injections are only admi-
nistered by trained health personnel within the existing
health system, using individuals who would already be
providing them routinely. Adverse events associated
with FCHV management of neonatal illness are
recorded.
Analysis strategies
The analysis will be undertaken as intention-to-treat at
both cluster and participant levels. Participants who
begin the trial as residents of a given cluster will be
retained as such even if they move to another cluster
during the trial period. The analysis will describe partici-
pant flow, deviations from protocol, recruitment and
potential sources of bias. A table will summarize base-
line characteristics of control and intervention clusters.
Seven clusters were included in the original randomi-
sation but excluded soon after because of political inse-
curity. No intervention activities took place in these
clusters. As a secondary analysis we shall also analyse
the trial findings with these clusters excluded from the
analysis.
We will have two sources of data for the primary mor-
tality outcomes, one nested within the other. First,
births and deaths identified and summarized as cluster-
level totals. Second, a sample of families (550 per
month) visited to collect detailed interview information.
Although this provides information on demography,
socioeconomic status, care practices and outcomes, our
presumption is that it will not exactly reflect population
mortality figures, since there are systematic differences
between the likelihoods of interviewing a bereaved
family and a family whose infant has survived. For this
reason, we suspect that that cluster-level figures are
likely to give the most accurate estimates of mortality
rates. We will therefore conduct two types of analysis: at
cluster level and at individual level.
The cluster-level analysis will begin with two-sample
t-tests, which are relatively robust to deviations from
normality. We will present 95% confidence intervals for
mortality rate differences. For event rates, we will fit a
Poisson regression model that ignores the intervention
effect, compare predicted with observed mortality rates,
and examine the effect of the intervention through a t-
test on the residuals[34]. For individual-level analysis,
we will use random effects logistic regression grouped
on clusters. If quadrature checks do not support the use
of this approach, we will consider using Generalized
Estimating Equations. Analyses will be adjusted for
socioeconomic status and religion.
The factorial nature of the evaluation design assumes
independence of effect of the two interventions on the
primary and secondary outcomes. We do not think that
the design will allow us to explore interaction beyond
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the speculative, and will present the findings in a table
that compares the four combinations of intervention
and control. Care practices, health care seeking beha-
viour, identification, treatment and referral of neonatal
sepsis by FCHVs will be presented in tables of frequen-
cies and percentages.
We will not know whether we have sufficient power
to compare separately the impact on mortality outcomes
of the first and second action cycles of the women’s
group until we see the effect size. We hope to analyse 2
blocks of 2 years (run-in year and year 1, and years 2-3)
to see the effect of the first cycle and then that of the
second in addition to the first. It will not be possible to
analyse the mortality impact of the second cycle inde-
pendently from that of the first, since strategies begun
in the first cycle will continue during the second. We
aim to compare the effect of the second cycle on nutri-
tion-related behaviours in comparison with the effect of
the first.
Qualitative information on activities resulting from
women’s groups will be analysed thematically. The trial
findings will be presented in accordance with CON-
SORT guidelines[35,36].
Ethical issues
Approvals
The study is being undertaken under a Memorandum of
Understanding with the Government of Nepal Ministry
of Health. It has ethical clearance from the Nepal Health
Research Council and the ethics committee of the Insti-
tute of Child Health and Great Ormond Street Hospital
for Children, UK.
Consent
After community-level meetings in each cluster, pre-
allocation signed consent was taken from cluster guar-
dians in the person of village development committee
secretaries. Participation in either a community group
or in the work of the FCHV is at the discretion of
families in Dhanusha district. Participation in the study
involves verbal consent to be interviewed about preg-
nancy, delivery and the newborn period. Participants
give verbal consent and are free to decline to be inter-
viewed at any time. All community-based members of
the study team were recruited locally and carry out
their activities in their home areas. When surveillance
team members note minor illness in mothers or
infants, they encourage attendance at an appropriate
health facility. In the event of severe illness, team
members have an ethical responsibility to assist with
rapid and appropriate transport and treatment, regard-
less of allocation. All information provided by partici-
pants remains confidential. Access to information is
limited to interviewers, supervisors, data auditors
and officers, and research staff at the analytical level.
No analyses or outputs will include the names of
participants.
Benefits to control areas
In order to provide support to existing health services in
both control and intervention areas, essential newborn
care training to all health cadres, an equipment audit
and provision of certain equipment for essential new-
born care was provided to health facilities throughout
Dhanusha district. Table 1 summarises the training and
equipment provided to control and intervention groups
to strengthen government health service provision for
mothers and newborns.
Sustainability and scalability
Both interventions have been designed and modified
with an emphasis on potential sustainability. MIRA
trained all health personnel in the district public health
system in essential newborn care and all health person-
nel in sepsis intervention areas in the management of
newborn sepsis. National bodies have ratified the train-
ing modules and MIRA is the primary trainer for new-
born care in Nepal. The Nepal Government will run
subsequent training.
The involvement of FCHVs in both interventions
represents a route to potential scale-up. Our experience
in the MIRA Makwanpur trial was that it would be pre-
ferable for interventions to be conceived from the begin-
ning in terms of best fit with existing human resources.
FCHVs are already responsible for ward-level mothers’
groups, and the MIRA Dhanusha community groups’
intervention builds directly on this. In the MIRA Dha-
nusha sepsis management intervention, initial training,
orientation and logistics are managed by MIRA, but in
partnership with regular district health system activities.
Monitoring and supervision will be transferred gradually
to the district health system so that at the end of the
study FCHVs will source drugs and supervision from
local health institutions under the supervision of the dis-
trict health office.
Public engagement
There will be a substantial increase in our knowledge
about perinatal and neonatal events and nutrition, and
an indication of whether demand-side interventions are
effective, scalable and replicable. We hope that this
research will help policymakers in Nepal and in other
developing countries to make informed choices about
the use of community health volunteers for treatment
and referral of sepsis, and the use of a new cadre of
reproductive health community health mobilisers to
concentrate on the demand rather than the supply side
obstacles to better maternal and child health. We also
think that the findings of the study will have implica-
tions for the community component of the Integrated
Management of Childhood Illness strategy and safer
motherhood and newborn care programmes.
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Additionally, the whole notion of the women’s group
intervention is predicated on potential sustainability and
cost-effectiveness. All MIRA-CIHD collaborative
research is carried out in partnership with the Govern-
ment of Nepal Ministry of Health. Representatives of
the Ministry (particularly the Family Health Division)
and the Nepal Health Research Council have been
involved in the development of our proposals to test
expansion of women’s group and community health
volunteer activities. The MIRA-CIHD collaboration and
the Ministry of Health meet regularly to discuss ongoing
research and how it might influence national policy and
practice. The trial findings will be published in an open
access peer-reviewed journal.
Project management and research governance
The MIRA-CIHD collaboration has a track record of
over 18 years of successful partnership. Local MIRA
employees control the management of research studies,
and UK inputs are purely technical and advisory. MIRA
handles all recruitment, administration and implementa-
tion aspects of the research. Established management
tools and performance controls are used, including
recruitment protocols, conditions of service and terms
of reference for all cadres. Senior UCL CIHD team
members visit MIRA for project review every three to
six months. Scientific papers submitted for publication
as a result of the studies will be subjected to peer
review. The responsibilities of the Data Monitoring
Committee will be to assess efficacy, adequacy of sample
size, and comparability of treatment arms, and to
approve the final analytic plan, including analysis that
takes account of loss of clusters.
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provision to mothers and newborns
Audit
All government health facilities
Newborn care equipment availability and function
Equipment
All government health facilities
Suction bulb
Weighing scale
Thermometer
Ambubag
All primary health centres
Warm cot
Resuscitaire
Phototherapy unit
Zonal hospital
2 warm cots
2 resuscitaires
2 phototherapy units
Consumables
All maternal and child health workers
2 wiping/wrapping cloths
Rubber suction bulb
Silicon tube and mask
Glass thermometer
30 ml betadine solution
30 ml gentian violet solution
Pictorial manual
Training
All government health workers in the district: essential newborn care
Benefits in sepsis management intervention clusters only
Consumables
All government health facilities in sepsis management intervention
clusters:
Injection gentamicin 80 mg (10 vials)
Disposable syringe 1 ml (50)
Tab amoxicillin DT 125 mg (50 tabs)
Recording forms
Training
All government health workers in sepsis management intervention
clusters: community-based sepsis management
All Female community health volunteers in sepsis management
intervention clusters: essential newborn care and community-based
sepsis management
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